The immunosuppressive macrolides FK-506 and rapamycin
- 31 July 1991
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 29 (1-2) , 105-111
- https://doi.org/10.1016/0165-2478(91)90209-s
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Influence of FK-506 and Low-Concentration Ciclosporin on Human Lymphocyte Activation Antigen Expression and Blastogenesis: a Flow Cytometric AnalysisScandinavian Journal of Immunology, 1990
- THE IMMUNOSUPPRESSIVE ACTION OF FK 506Transplantation, 1990
- T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506Immunology Letters, 1989
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- EFFECT OF A NOVEL IMMUNOSUPPRESSIVE AGENT, FK506, ON MITOGEN-INDUCED INOSITOL PHOSPHOLIPID DEGRADATION IN RAT THYMOCYTESTransplantation, 1989
- EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITROTransplantation, 1989
- PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL IN RATS TREATED WITH 15-DEOXYSPERGUALIN ALONE AND IN COMBINATION WITH FK506Transplantation, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOGTransplantation, 1987